MORRISVILLE – Syneos Health is now a private company, having wrapped up its deal valued at some $7 billion with private equity partners Elliott Investment Management L.P., Patient Square Capital and Veritas Capital.
The deal for the biopharma services company closed Thursday.
Syneos has some 29,000 employees.
Shares were delisted Thursday. Investors received $43 for each share of common stock.
The deal was first announced in May.
“With the support of its new private investors, the Company will be poised to further accelerate its transformation, fuel investments in technology that better differentiate its integrated solutions and expand its commitment to better serve customers,” Syneos said in a statement.